These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 23553192

  • 1. Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice.
    Lee SW, Park KH, Park S, Kim JH, Hong SY, Lee SK, Choi D, Park YB.
    Arthritis Rheum; 2013 Jul; 65(7):1902-12. PubMed ID: 23553192
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of nephritis in lupus-prone mice by thalidomide.
    Lee SW, Park YB, Yang J, Park KH, Lee SK, Choi KH, Kim BS.
    Rheumatology (Oxford); 2012 Dec; 51(12):2131-40. PubMed ID: 22923758
    [Abstract] [Full Text] [Related]

  • 3. Comparison of therapeutic efficacy between bortezomib and combination treatment of prednisolone and mycophenolate mofetil on nephritis in NZB/WF1 mice.
    Lee SW, Kim BS.
    Clin Exp Rheumatol; 2010 Dec; 28(3):393-6. PubMed ID: 20497633
    [Abstract] [Full Text] [Related]

  • 4. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 5. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
    Mun CH, Kim JO, Ahn SS, Yoon T, Kim SJ, Ko E, Noh HD, Park YB, Jung HJ, Kim TS, Lee SW, Park SG.
    Biomaterials; 2019 Nov; 220():119408. PubMed ID: 31394431
    [Abstract] [Full Text] [Related]

  • 6. Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid.
    Yung S, Zhang Q, Zhang CZ, Chan KW, Lui SL, Chan TM.
    Arthritis Rheum; 2009 Jul; 60(7):2071-82. PubMed ID: 19565476
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 8. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
    Nozaki Y, Yamagata T, Yoo BS, Sugiyama M, Ikoma S, Kinoshita K, Funauchi M, Kanamaru A.
    Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
    [Abstract] [Full Text] [Related]

  • 9. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
    Zoja C, Benigni A, Noris M, Corna D, Casiraghi F, Pagnoncelli M, Rottoli D, Abbate M, Remuzzi G.
    Kidney Int; 2001 Aug; 60(2):653-63. PubMed ID: 11473648
    [Abstract] [Full Text] [Related]

  • 11. The role of aldosterone blockade in murine lupus nephritis.
    Monrad SU, Killen PD, Anderson MR, Bradke A, Kaplan MJ.
    Arthritis Res Ther; 2008 Aug; 10(1):R5. PubMed ID: 18197980
    [Abstract] [Full Text] [Related]

  • 12. Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice.
    Lee H, Kim H, Lee G, Chung HS, Bae H.
    Br J Nutr; 2013 Jul 14; 110(1):69-76. PubMed ID: 23181951
    [Abstract] [Full Text] [Related]

  • 13. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway.
    Hu Q, Yang C, Wang Q, Zeng H, Qin W.
    PLoS One; 2015 Jul 14; 10(7):e0133724. PubMed ID: 26208003
    [Abstract] [Full Text] [Related]

  • 14. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
    F L, Y T, X P, L W, H W, Z S, H Z, Z H, MMF in Induction Therapy for Active Lupus Nephritis in Mainland China Study Group.
    Lupus; 2008 Jul 14; 17(7):622-9. PubMed ID: 18625634
    [Abstract] [Full Text] [Related]

  • 15. Dioscin attenuates lupus nephritis in NZB/W F1 mice by decreasing NF-κB activation and NLRP3 inflammasome.
    Xu Y, Li H.
    Folia Histochem Cytobiol; 2024 Jul 14; 62(2):110-121. PubMed ID: 39042029
    [Abstract] [Full Text] [Related]

  • 16. Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB × NZW) F1 mice.
    Fismen S, Mortensen ES, Rekvig OP.
    Immunol Cell Biol; 2011 Jan 14; 89(1):90-9. PubMed ID: 20548325
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model.
    Cheng CC, Lee YF, Lan JL, Wu MJ, Hsieh TY, Lin NN, Wang JM, Chiu YT.
    Lupus; 2013 May 14; 22(6):554-61. PubMed ID: 23478030
    [Abstract] [Full Text] [Related]

  • 18. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
    Lui SL, Yung S, Tsang R, Zhang F, Chan KW, Tam S, Chan TM.
    Lupus; 2008 Apr 14; 17(4):305-13. PubMed ID: 18413412
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW, Elbourne KB, Lagoo A, Lal S.
    J Rheumatol; 1998 Dec 14; 25(12):2364-70. PubMed ID: 9858431
    [Abstract] [Full Text] [Related]

  • 20. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
    Li X, Wang M, Hong H, Luo C, Liu Z, Yang R.
    Immunol Res; 2018 Aug 14; 66(4):521-527. PubMed ID: 30047025
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.